European Pharmaceutical Review

DECEMBER 20, 2023

1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. The potential for a mandatory ‘return on investment’ assessment could lead to loss of orphan designation if the therapy is deemed ‘sufficiently profitable’.

Biopharma 98

Biopharma Pharmaceutical Medicine Manufacturing 98

Healthcare Success

JULY 5, 2022

How to create marketing and lead generation systems that get results. Editor’s Note: I wrote the first version of this blog post back in 2006 when we launched Healthcare Success. Thus, marketing and lead acquisition costs can quickly spiral to the point of unprofitability. Lead Generation Best Practices.

Doctors 57

Doctors Physicians Marketing Healthcare 57

European Pharmaceutical Review

DECEMBER 19, 2022

1 However, as most biosimilars are developed by means of a complex biotechnological process in living organisms, this inevitably leads to differences between the biosimilar and the reference product. Marie Manley leads Sidley’s Life Sciences team in London and is a distinguished thought leader and adviser on EU and UK regulatory law.

Medicine 52

Medicine Biopharma Safety Food 52

Pharmaceutical Technology

MARCH 24, 2023

Currently, 40 biosimilars are FDA-approved and 25 have launched, whereas the EMA has approved 86 biosimilars since 2006. Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. The primary reasons for delayed market entry in the US revolve around patent disputes.

Competition 59

Competition Marketing FDA Physicians 59

Clarivate

NOVEMBER 10, 2022

The evidence standards that a COA must meet to support key clinical trial endpoints have become increasingly stringent in recent decades, following the introduction of the United States Food and Drug Administration (FDA) Patient Reported Outcomes (PRO) draft guidance in 2006, followed by the full guidance in 2009.

Patients 52

Patients Food and Drug Administration FDA Safety 52

Pharmaceutical Technology

OCTOBER 5, 2008

But the recent acquisition by Japanese pharmaceutical provider Shionogi of US-based rival Sciele Pharma, worth $1,276m, is just the latest in a spree of big and bold outbound deals. “Local generic companies such as Ranbaxy and DRL have expanded through acquisition in Western markets aggressively in 2006.”

Government 40

Government Marketing Pharmaceutical Physicians 40

Clarivate

NOVEMBER 13, 2023

The work, said lead investigator Brett King, Associate Professor at Yale Dermatology, “helped change the landscape of alopecia areata forever.” Most importantly, newly approved treatments can address significant unmet needs for patients living with severe alopecia areata.

Patients 52

Patients Food and Drug Administration FDA Safety 52

Pharmaceutical Technology

AUGUST 26, 2008

However, a wave of exciting monoclonal antibody products was being developed, and these were quickly partnered with big pharma which demonstrated the increasing commercial opportunity for biotechnology. “There have been doubts about the extent to which the high prices paid by big pharmaceuticals were justified in the short term.”

Pharmaceutical 40

Pharmaceutical Manufacturing Biopharma Medicine 40

Evolve Your Success

JANUARY 10, 2023

A lot of our readers are trying to get into medical sales, whether it be pharma, medical device, or something in between. It’s the MedTech versus medical devices, and we have the pharma division. Leading up to my senior year, I had some great internships in Manhattan, New York, working on some of the biggest brands in the world.

Sales 52

Sales Medical sales Consulting Medical 52

World of DTC Marketing

DECEMBER 10, 2020

Pharma companies continue to be among the most profitable industries, even outperforming tech companies. The Pharma Spin. Pharma continues to spin the lie about the high development costs of drugs but an analysis tells us the truth. This is an industry that doesn’t care about what people think of them.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Medico Reach

JUNE 29, 2022

The company specializes in many different areas of the healthcare sector, such as biotech, pharma, etc. via their industry-leading illustration technology and analytics. Mindspot Research has been an expert in online market research since 2006. So, let’s get started. Lucid Health. Applied Marketing Science (AMS).

Healthcare 98

Healthcare Healthcare Marketing Specialization 98

Pharma Marketing Network

JUNE 11, 2020

With me, today is John Mack, the original creator of Pharma Marketing and also known as Pharma Guy from far and wide. And I was surprised to see a letter on the homepage that said, “Hey, Pharma folks, I’m retiring. And bring back some memories for folks of pharma guy and how he came to be. Thanks for coming John.

Media 52

Media Pharma Ethics Consulting 52

Pharma Marketing Network

JULY 7, 2021

O’Connor will succeed current President and CEO Laurie Cooke, who will step down for a well-earned retirement after leading the organization since 2006. As a transformational leader, Susan is perfectly suited to lead the HBA as it cultivates the. improvements necessary in the international healthcare ecosystem. Bina added. “I

Healthcare 52

Healthcare Healthcare Networking Leads 52

Healthcare Success

OCTOBER 30, 2024

Find out in our latest podcast featuring Danielle Wiley, CEO of Sway Group, a leading influencer marketing agency. I don't know if you remember this, Danielle, but there was a book called Here Comes Everybody that came out, probably around 2006, 2008, and it talked about exactly something you just mentioned there, which is that?

Marketing 113

Marketing Healthcare Healthcare Networking 113